Evidence map›Paper›PMID 27672152›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2016

Old concepts, new molecules and current approaches applied to the bacterial nucleotide signalling field.

Angelika Gründling, Vincent T Lee

Abstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. What bacteria want.Environmental microbiology · 2018
    Review
  7. Article
  8. The new bacteriology.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Angelika GründlingSection of Microbiology and MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London SW7 2AZ, UK a.grundling@imperial.ac.uk.ORCID 0000-0002-6235-8687
Vincent T LeeDepartment of Cell Biology and Molecular Genetics, University of Maryland at College Park, College Park, MD 20742, USA vtlee@umd.edu.ORCID 0000-0002-3593-0318

Funding

Catheter associated urinary tract infection by Pseudomonas aeruginosaR01AI110740 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI LEE, VINCENT T · 2016 to 2020
$2.0M
Medical Research Council MR/J006874/1NIAID NIH HHS R01 AI110740Wellcome Trust 100289
6 · The paper itself

Abstract

Signalling nucleotides are key molecules that help bacteria to rapidly coordinate cellular pathways and adapt to changes in their environment. During the past 10 years, the nucleotide signalling field has seen much excitement, as several new signalling nucleotides have been discovered in both eukaryotic and bacterial cells. The fields have since advanced quickly, aided by the development of important tools such as the synthesis of modified nucleotides, which, combined with sensitive mass spectrometry methods, allowed for the rapid identification of specific receptor proteins along with other novel genome-wide screening methods. In this review, we describe the principle concepts of nucleotide signalling networks and summarize the recent work that led to the discovery of the novel signalling nucleotides. We also highlight current approaches applied to the research in the field as well as resources and methodological advances aiding in a rapid identification of nucleotide-specific receptor proteins.This article is part of the themed issue 'The new bacteriology'.

Indexed as

Bacterial Physiological PhenomenaSignal TransductionNucleotidesTranscription FactorsNucleotidesTranscription Factorsbacteriabiosensoreffector proteinnucleotide detectionreceptor proteinsignalling nucleotide

Identifiers

PMID27672152
PMCPMC5052745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.